Hansjorg Urbach

This inventor holds 63 USPTO granted patents, primarily in Cardiovascular Pharmaceuticals (CPC class 5484). Top assignee: Hoechst Aktiengesellschaft. Active years: 1985-1998.

USPTO Granted Patents = 63

% Patents Active = 100.0

Average Co-Inventor Count = 3.9

ph-index = 17

Forward Citations = 725(Granted Patents)

Forward Citations (Not Self Cited) = 527(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Kronberg/Tannus, DE (1990)
Kronbert, DE (1990)
Kronberg, DE (1985 - 1993)
Taunus, DE (1991 - 1993)
Kronberg/Taunus, DE (1987 - 1998)

Company Filing History:

63 out of 6,705

Hoechst Aktiengesellschaft

patents

Years Active: 1985-1998

Loading Chart...

Areas of Expertise:

Cardiac Insufficiency

Angiotensin-Converting Enzyme

Renin-Inhibiting

Amino Acid Derivatives

Pharmaceutical Composition

Psychotropic Action

Dipeptide Derivatives

Vascular Hypertrophy

Cognition Adjuvant

Bicyclic Amino Acids

Calcium Combination

Octahydroindole

63 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5747504 - Method of treating cardiac insufficiency using angiotensin-converting (1998-05-05),

2. 5744496 - Method of treating cardiac insufficiency using angiotensin-converting (1998-04-28),

3. 5684016 - Method of treating cardiac insufficiency (1997-11-04),

4. 5500434 - Combination of angiotensin-converting enzyme inhibitors with calcium (1996-03-19),

5. 5403856 - Method of treating cardiac insufficiency using angiotensin-converting (1995-04-04),

6. 5401766 - Aminoacid derivatives, a process for their preparation, agents (1995-03-28),

7. 5374731 - Amino acid derivatives with renin-inhibiting properties, a process for (1994-12-20),

8. 5366994 - Use of a combination of angiotensin-converting enzyme inhibitor and (1994-11-22),

9. 5360791 - Renin-inhibiting aminodiol derivatives (1994-11-01),

10. 5256687 - Pharmaceutical composition for the treatment of high blood pressure (1993-10-26),

11. 5236943 - Method for the treatment of cardiac and of vascular hypertrophy and (1993-08-17),

12. 5236933 - Use of a combination of angiotensin-converting enzyme inhibitor and (1993-08-17),

13. 5235057 - Aminodiol derivatives (1993-08-10),

14. 5231084 - Compounds having a cognition adjuvant action, agents containing them, (1993-07-27),

15. 5231083 - Method for the treatment of cardiac and of vascular hypertrophy and (1993-07-27),

As an AI assistant at idiyas.com, I'll provide you with an article about the accomplished inventor, Hansjorg Urbach.

Title: The Innovative Journey of Hansjorg Urbach

Introduction:

Hansjorg Urbach, a renowned inventor, hails from Kronberg/Taunus, Germany. With an impressive portfolio of 63 patents, he has made significant contributions to the field of inventions and continues to inspire future innovators.

Latest Patents:

One of Urbach's latest patents involves a groundbreaking method for treating cardiac insufficiency using angiotensin-converting compounds. This innovative approach underscores his commitment to developing life-changing solutions for medical challenges.

Career Highlights:

Having worked at Hoechst Aktiengesellschaft and Hoechst Aktiengesellschaft, Urbach has honed his skills and expertise in the pharmaceutical industry. His career highlights reflect a dedication to pushing the boundaries of scientific discovery and improving healthcare outcomes.

Collaborations:

Throughout his career, Urbach has collaborated with esteemed colleagues such as Rainer Henning and Volker Teetz. These partnerships have led to the successful development and implementation of cutting-edge technologies in the medical field.

Conclusion:

In conclusion, Hansjorg Urbach's journey as an inventor exemplifies the transformative power of innovation and creativity. His relentless pursuit of scientific excellence has not only advanced the field of medicine but has also paved the way for future generations of inventors to follow in his footsteps.